Sanofi India share price: Sharekhan retains Buy ratingwith a revised price target of Rs 9600
Sanofi India had hosted an investor webinar to discuss the business updates and management’s commentary was positive, pointing towards a healthy growth outlook for the company. The Indian Pharmaceutical Market (IPM) has recovered posting a growth of 5% yoy for October 2020 - February 2021 as compared to a 2.5% decline in first half of FY21.
Sharekhan retains Buy rating on Sanofi India with a revised price target of Rs 9600: Reuters